Browse Category

Stock Market News 15 January 2026

Merck stock slips as FDA fast-track delays grab attention ahead of Feb. 3 earnings

Merck stock slips as FDA fast-track delays grab attention ahead of Feb. 3 earnings

Merck shares fell 0.2% to $110.75 Thursday after the FDA delayed decisions in its new voucher fast-track program, according to Reuters. The FDA postponed reviews of drugs from Sanofi, Disc Medicine, and Eli Lilly, citing safety concerns. Investors are watching for Merck’s Feb. 3 earnings and updates on its drug pipeline. Healthcare stocks broadly declined, with Eli Lilly down 3.6%.
Amphenol (APH) stock jumps 6% as Goldman lifts target and company tees up ADC India open offer

Amphenol (APH) stock jumps 6% as Goldman lifts target and company tees up ADC India open offer

Amphenol shares jumped 6.4% to $156.13 after the company filed an open offer to buy 26% of ADC India, following its $10.5 billion CommScope deal. Goldman Sachs, BofA, and UBS raised price targets, citing strong data-center demand. The open offer totals about $16.4 million if fully accepted. Investors await Amphenol’s Jan. 28 earnings call for updates on integration and order trends.
15 January 2026
Bloom Energy stock jumps 8% as EIA flags data-center power surge

Bloom Energy stock jumps 8% as EIA flags data-center power surge

Bloom Energy shares jumped 8% to $144.11 Thursday, hitting a new intraday high amid investor focus on rising electricity demand from data centers. The move follows American Electric Power’s $2.65 billion deal to buy Bloom’s fuel cells for a Wyoming facility. Broader clean energy stocks also rose, while Bloom’s rivals fell. The EIA will release updated U.S. energy demand forecasts on February 10.
Pfizer stock edges higher as vaccine-policy jitters and obesity race frame the next catalyst

Pfizer stock edges higher as vaccine-policy jitters and obesity race frame the next catalyst

Pfizer shares rose 0.3% to $25.67 Thursday as investors weighed U.S. vaccine policy debates and the company’s growth outlook. The stock moved between $25.26 and $25.67 with 22.3 million shares traded. Pfizer will report Q4 results on Feb. 3, with guidance projecting 2026 revenue of $59.5–$62.5 billion and lower COVID-19 product sales. Competition in obesity drugs and AI-driven drug discovery remain in focus.
Morgan Stanley stock jumps as Wall Street deal talk returns after Q4 earnings

Morgan Stanley stock jumps as Wall Street deal talk returns after Q4 earnings

Morgan Stanley shares rose 5.9% to $191.41 after reporting fourth-quarter net revenues of $17.89 billion and earnings of $2.68 per share. Investment banking revenue reached $2.41 billion, and net new assets in wealth management totaled $122.3 billion. The board declared a $1.00 quarterly dividend and repurchased $1.5 billion in stock. Investors focused on rising deal activity and the upcoming Federal Reserve meeting.
Silverstock Metals stock jumps 20% as silver’s record run whipsaws traders

Silverstock Metals stock jumps 20% as silver’s record run whipsaws traders

Silverstock Metals (CSE:STK) jumped 20% to C$0.24 in thin Thursday trading, tracking silver’s volatile run after the metal hit a record $93.57 an ounce before sliding 2.4%. TD Securities closed a short silver position after losses, citing strong demand and supply issues. Silverstock holds exploration claims in British Columbia but does not produce metal. Investors are watching Fed policy signals and upcoming data.
15 January 2026
Coinbase stock slides as Senate delays crypto bill, putting bitcoin-linked shares back on edge

Coinbase stock slides as Senate delays crypto bill, putting bitcoin-linked shares back on edge

Coinbase shares fell 3.3% Thursday after the Senate Banking Committee delayed a crypto market-structure bill markup. Bitcoin slipped 0.6% to $96,418, pulling down related stocks. The delay followed Coinbase’s withdrawal of support for the draft, with CEO Brian Armstrong citing concerns over stablecoin rewards and regulatory limits. Traders are watching for signs of a rescheduled committee vote.

Stock Market Today

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

7 February 2026
Lucid Group shares jumped 14% to $10.86 at Friday’s close, recovering from an 8% drop the previous day. The move followed a broad Wall Street rally that lifted high-volatility stocks. Lucid reported fourth-quarter deliveries of 5,345 vehicles and full-year deliveries of 15,841. Investors await Lucid’s Feb. 24 results for updates on cash and demand.
Go toTop